SCHEMBL10079145

SCHEMBL10079145

CN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 11/20 0.64
OPRM1 P35372 9/20 0.62
OPRD1 P41143 4/20 0.62
OPRK1 P41145 4/20 0.60
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 1/20 0.55
MAPT P10636 1/20 0.55
RAB9A P51151 1/20 0.55
ABCB11 O95342 1/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
THPO P40225 1/20 0.55
MTOR P42345 1/20 0.55
EBP Q15125 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
MEN1 O00255 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31557722 0.85 OPRL1 (0.62) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL10057650 0.84 OPRL1 (0.63) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL18029400 0.84 OPRL1 (0.70) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL26706222 0.82 OPRL1 (0.59) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL30227020 0.82 OPRL1 (0.59) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL10640602 0.82 SLC6A2 (0.48) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL10638058 0.81 LMNA (0.46) OPRL1OPRM1OPRD1OPRK1
SCHEMBL28796806 0.81 OPRM1 (0.60) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL2925749 0.81 OPRM1 (0.63) OPRL1OPRM1OPRD1OPRK1SMN1; SMN2
SCHEMBL18767237 0.81 OPRL1 (0.61) OPRL1OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148404-B2 Modulators of CB1 receptors 7TM PHARMA A/S (DK) 2012-04-03 US disclosed
US-20100144701-A1 Modulators of CB1 Receptors 7TM PHARMA A/S (DK) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144701-A1 Modulators of CB1 Receptors CNR1, CNR2, GPR6 OPRL1 23/4885OPRM1 81/4885OPRD1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.